Ann: PAT-DX1 significantly improves survival in aggressive GBM, page-9

There have been so may bio-techs that have proven animal results but then fallen over when it comes to human trials, either no approval or zero result.

Whilst PAB is a frustrating stock to hold: Announcement goes out on progress, SP shoots 30% then drifts back even in the same day. But, all precursors to the big one IMO as boxes are being very slowly, but VERY methodically ticked off.

IMO this is one of the last ticks before Dr Campbell and team announce they will be proceeding to Human Trials, and as frustrating a hold as it has been, they are way ahead of the game for that.

I'm not re-mortgaging the shack to buy more yet.....but very close.